Singapore sovereign fund GIC will invest an additional $150 million in Asia Healthcare Holdings (AHH) ahead of a potential initial public offering (IPO). The investment will make GIC the largest shareholder in AHH, and follows GIC's first investment of $170 million in the platform in February 2022.
The investment will likely value AHH at $800-900 million, according to a person aware of the development.
With the latest transaction, global private equity firm TPG will transition to a minority stakeholder in the healthcare platform, and GIC will hold the majority stake, according to the healthcare platform's release on Wednesday.
Esta historia es de la edición December 19, 2024 de Mint Bangalore.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición December 19, 2024 de Mint Bangalore.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Market indices flashing red shouldn't stop IPOs
India's stock market correction has slowed share issuance down. Risk-off investor behaviour; however, does not mean value offers will be overlooked. Confident issuers should go ahead
CleanMax, Osaka Gas Announce JV
Brookfield-backed firm CleanMax on Monday announced a joint venture partnership with Osaka Gas Group to develop a 300 megawatts (MW) renewable energy portfolio entailing an investment of ₹1,500 crore.
Vanuatu PM cancels Lalit Modi passport
Vanuatu Prime Minister Jotham Napat on Monday directed the Citizenship Commission to cancel the passport issued to Indian Premier League (IPL) founder Lalit Modi, saying that the fugitive was attempting to avoid his extradition.
Honda Cars India names new CEO
Japanese automaker Honda on Monday said it has appointed Takashi Nakajima as the new president and chief executive officer of Honda Cars India.
Sun Pharma to buy US oncology firm for $355 million
Sun Pharmaceutical Industries Ltd has agreed to buy US-based immunotherapy and oncology firm Checkpoint Therapeutics Inc. for an upfront payment of $355 million, as India's largest drugmaker bolsters its specialty therapy portfolio.
Chhaava's on-screen success fails to light up PVR Inox stock
Flop show
India, EU resume FTA negotiations
India and the European Union (EU) resumed talks for a free trade agreement on Monday after a gap of more than five months, against the backdrop of a fragmented global economic order.
How to brace for 'beggar thy neighbour' trade policies
An exporter like China will need to focus on efficiency while India could use US policy to its trade advantage
Cognizant on a tightrope as new challenge pops up
Globally, 243 activist campaigns were launched in 2024, highest since 2018, according to a Barclays report
Commercial vehicle vol to grow in FY26
Domestic commercial vehicle industry's wholesale volumes are expected to grow 3-5% year-on-year in the financial year 2026, rating firm Icra said in a statement on Monday.
